221 related articles for article (PubMed ID: 9655997)
1. Prostate carcinoma: clarification through clinical insight and molecular diagnostics.
Meyers FJ; DeVere White RW
West J Med; 1998 Jun; 168(6):525. PubMed ID: 9655997
[No Abstract] [Full Text] [Related]
2. [Screening with PSA (Prostate Specific Antigen) raises ethical questions].
Taube A
Lakartidningen; 1996 Sep; 93(39):3341. PubMed ID: 8926796
[No Abstract] [Full Text] [Related]
3. Efficacy vs effectiveness in prostate-specific antigen screening.
Albertsen PC
J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583
[No Abstract] [Full Text] [Related]
4. [Prostate cancer screening using prostate-specific antigen (PSA) determinations in plasma. National Academy of Medicine].
Bourel M; Ardaillou R;
Bull Acad Natl Med; 2003; 187(5):985-95. PubMed ID: 14979060
[TBL] [Abstract][Full Text] [Related]
5. PSA testing.
Frydenberg M
Aust Fam Physician; 2003 Jun; 32(6):396. PubMed ID: 12833760
[No Abstract] [Full Text] [Related]
6. [Diagnostic value of tissue and serum prostate specific antigen in prostate cancer].
Medvedev VL
Voen Med Zh; 2004 Feb; 325(2):50-4. PubMed ID: 15101295
[No Abstract] [Full Text] [Related]
7. Patient education. PSA: pros and cons.
Gattellari M; Ward JE
Aust Fam Physician; 2003 Jun; 32(6):429-30. PubMed ID: 12833769
[No Abstract] [Full Text] [Related]
8. Prostate cancer: enthusiasm for screening.
Kaye KW
Med J Aust; 1995 May; 162(10):540-1. PubMed ID: 7539884
[No Abstract] [Full Text] [Related]
9. Update on screening for prostate cancer with prostate-specific antigen.
Schmid HP; Riesen W; Prikler L
Crit Rev Oncol Hematol; 2004 Apr; 50(1):71-8. PubMed ID: 15094160
[TBL] [Abstract][Full Text] [Related]
10. Non-systematic screening for prostate cancer in Sweden--survey from the National Prostate Cancer Registry.
Stattin P; Johansson R; Damber JE; Hellström M; Hugosson J; Lundgren R; Varenhorst E; Johansson JE
Scand J Urol Nephrol; 2003; 37(6):461-5. PubMed ID: 14675917
[TBL] [Abstract][Full Text] [Related]
11. Clinical diagnosis and staging of prostatic carcinoma.
Alcini E; D'Addessi A
Rays; 1993; 18(1):3-13. PubMed ID: 7689236
[No Abstract] [Full Text] [Related]
12. Best screening tests for prostate cancer.
Moul JW
West J Med; 1998 Aug; 169(2):109-10. PubMed ID: 9735692
[No Abstract] [Full Text] [Related]
13. [Markers of prostatic carcinoma].
Safarík L
Cas Lek Cesk; 1998 Aug; 137(17):525-7. PubMed ID: 9787505
[TBL] [Abstract][Full Text] [Related]
14. [Prostate cancer screening].
Saksela E
Duodecim; 1997; 113(9):871. PubMed ID: 11466912
[No Abstract] [Full Text] [Related]
15. [Cancer of the prostate: advances in the use of PSA and its derived indices--new tumor markers].
Zlotta A; Schulman C
Rev Med Brux; 1999 Sep; 20(4):A201-5. PubMed ID: 10523893
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer: screening and early detection.
Tariman JD
Adv Nurse Pract; 2006 Sep; 14(9):20. PubMed ID: 16972436
[No Abstract] [Full Text] [Related]
17. Application of prostate-specific antigen in prostate cancer.
Liang SL
MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558
[No Abstract] [Full Text] [Related]
18. Testing for prostate cancer. A consumer view.
Gardner M
Aust Fam Physician; 2003 Jun; 32(6):398-9. PubMed ID: 12833762
[No Abstract] [Full Text] [Related]
19. Is additional testing necessary in men with prostate-specific antigen levels of 1.0 ng/mL or less in a population-based screening setting? (ERSPC, section Rotterdam).
Roobol MJ; Roobol DW; Schröder FH
Urology; 2005 Feb; 65(2):343-6. PubMed ID: 15708050
[TBL] [Abstract][Full Text] [Related]
20. Is an improved PSA screening test in sight?
Savage L
J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
[No Abstract] [Full Text] [Related]
[Next] [New Search]
